Plain Language Summary & Lay Abstract Word Limits: Publisher Rules
When a journal or review body asks for a Plain Language Summary or lay abstract, standard abstract rules no longer apply. Here are the exact word limits, placement traps, and publisher AI policies you need to follow.
HumanPen Team
· 9 min read
Plain Language Summary and Lay Abstract Word Limits across Major Publishers
When submitting a Plain Language Summary (PLS) or lay abstract alongside a technical manuscript, word limits depend entirely on the target publisher: journal publishers like Taylor & Francis recommend 250 words or less, Wiley benchmarks lay summaries at 200 words, and the UK NHS Health Research Authority (HRA) limits sentence length to 20 words and paragraphs to 3 sentences. In sharp contrast, Cochrane mandates a strict floor and ceiling of 400 to 850 words (including the title), integrated into its 12,000-word review ceiling effective July 2026.
Beyond word limits, a Plain Language Summary requires the exact opposite reporting style of a technical abstract: Cochrane and NHS guidelines explicitly prohibit statistical metrics such as confidence intervals, P-values, and GRADE jargon like "risk of bias". Furthermore, publishers regulate AI assistance differently: Taylor & Francis permits AI-assisted PLS drafting of authors' own work under a mandatory four-point declaration, whereas Wiley forbids AI tools that claim training rights over submitted manuscripts.
Publisher Word Limits, Placement Rules, and Jargon Bans Compared
Navigating plain-language requirements requires understanding whether a summary is embedded directly into the primary manuscript file or purchased as a separate post-publication promotional feature. Failing to observe format and placement rules can result in submission desk rejections, broken indexation on databases like PubMed, or unexpected author fees.
| Publishing Body / Organization | Word Limit (Floor & Ceiling) | Manuscript Placement & Indexing | Statistical & Jargon Restrictions | AI Assistance Policy |
|---|---|---|---|---|
| Cochrane (Systematic Reviews & Protocols) | 400 to 850 words (including title); part of 12,000-word review total | Dedicated standalone section in RevMan; indexed in Cochrane Library | Strict ban on summary statistics, confidence intervals, and GRADE jargon (e.g., 'risk of bias') | Transparent reporting; author retains full responsibility for plain-language accuracy |
| Taylor & Francis | 250 words or less (recommended) | Option #1: In .docx after Abstract, before Introduction (Free, indexed on PubMed); Option #2 post-publication: $1,200/€1,000/£850 (not on PubMed) | Plain text continuous prose; accessible to non-specialists; avoid technical jargon | Explicitly permitted for PLS if original/revised drafts kept and 4-point AI declaration included |
| Wiley (Journals & Editing Services) | 200-word benchmark (Lay Summary); journal-specific in-article limits | Standalone promotional summary or within article per specific journal Author Guidelines | Clear, non-technical language avoiding disciplinary acronyms and complex equations | Substantial development/translation requires transparent disclosure; prohibits AI claiming training rights |
| UK NHS Health Research Authority (HRA) & NIHR | Form-specific word limits (e.g., 300–450 words in application boxes); no universal limit | Integrated into research application form and public summary registries | Sentences up to 20 words; paragraphs up to 3 sentences; neutral tone; no prior knowledge assumed | Researcher responsibility; must involve patients or public representatives in review |
The financial and discoverability implications at Taylor & Francis warrant particular attention. Submitting a text PLS under Option #1—pasted directly inside the submitted Microsoft Word document under the heading "Plain Language Summary" between the Abstract and the Introduction—is free, undergoes peer review alongside the technical study, and is indexed on PubMed. In contrast, opting for Option #2 after publication incurs a steep fee of $1,200 (€1,000 / £850) and results in a supplementary document that is not added to the typeset article nor indexed on PubMed.
Why Shrinking a Scientific Abstract Fails as a Plain Language Summary
Authors often assume that creating a Plain Language Summary simply means shortening an existing academic abstract to fit a lower word limit. However, a technical abstract and a plain-language summary serve opposite communicative functions. While academic abstracts often require rigorous statistical metrics and concise condensation, as outlined in our guide on shortening an academic abstract to 250 words, plain-language guidelines deliberately exclude dense technical jargon and complex statistical reporting.
Cochrane's official plain-language guidance explicitly instructs authors not to report summary statistics and confidence intervals, and not to use technical phrases like "risk of bias" or "low-/moderate-/high-certainty evidence". Authors must provide 2 to 3 "Key messages" bullet points summarizing findings and implications, without making any treatment recommendations.
Readability frameworks such as those published by the UK NHS Health Research Authority (HRA) enforce cognitive accessibility rather than numerical compression. In its guidance on writing plain-language summaries of research findings, the HRA advises researchers to construct sentences of up to 20 words, keep paragraphs to 3 sentences or fewer, adopt a neutral tone, and assume no prior specialist knowledge among readers. Compressing a 45-word academic sentence containing complex clauses into a dense 30-word sentence still overwhelms a lay reader; true condensing requires untangling academic syntax into digestible statements.
- Translate relative statistics into natural frequencies: Instead of quoting relative risk ratios, odds ratios, or hazard ratios with confidence intervals, explain outcomes using whole numbers out of 100 or 1,000 individuals.
- Convert methodology into concrete real-world actions: Replace abstract descriptors like double-blind placebo allocation with straightforward descriptions explaining that neither the trial participants nor the doctors knew who received the active drug or an inactive dummy pill.
- Enforce sentence-level breathing room: Eliminate passive constructions and academic nominalizations (such as changing "utilization was observed to decline" to "fewer people used"), splitting multi-clause compound sentences into standalone statements under 20 words.
Publisher AI Policies Specifically for Plain Language Summaries
Major academic publishers draw a sharp distinction between drafting original research manuscripts and generating plain-language summaries using artificial intelligence. While generative AI is broadly barred from drafting original research articles, Taylor & Francis (`authorservices.taylorandfrancis.com`) explicitly permits AI-assisted drafting of a Plain Language Summary for an author's own work, provided authors include a formal four-point `Declaration of AI use`. However, these four requirements are specific to Taylor & Francis rather than universal; authors submitting elsewhere must review publisher-specific policies, such as those from Cochrane, Wiley, AGU, or Elsevier. For a cross-publisher overview, see our guide on publisher AI disclosure policies.
- Author accuracy verification and named responsibility: Taylor & Francis requires the declaration to confirm that the originality and factual accuracy of the plain summary were verified by the authors, explicitly naming which specific co-author took responsibility for checking the text.
- AI software identification and exact version: Authors must disclose the complete tool name and version number used during the drafting or summarizing workflow.
- Terms of use and publication suitability check: The statement must confirm that the authors reviewed the specific AI tool's terms of service and verified that its outputs are legally and ethically suitable for academic publication.
- Full authorial liability for integrity and citations: Authors must declare full responsibility for the overall integrity of the summary, explicitly including the accuracy of all referenced facts and citations.
Beyond the four-point statement, Taylor & Francis requires authors to retain both original pre-AI drafts and revised versions to share upon editorial request. In parallel, Wiley's Ethics Guidelines mandate transparent disclosure whenever AI technology is used to substantially develop, edit, or translate manuscript sections (while exempting routine spelling and grammar checks). Furthermore, Wiley enforces a strict rights-protection clause: authors must ensure that the AI tool provider does not gain any proprietary rights over the underlying research, explicitly prohibiting tools that claim the right to train their models on submitted content.
Condensing a Plain Language Summary in Word Documents Without Editorial Violations
When preparing a manuscript in Microsoft Word (`.docx`), authors frequently encounter word-budget friction. An initial plain-language draft typically balloons to 350 or 400 words, exceeding Taylor & Francis's 250-word ceiling or Wiley's 200-word lay summary benchmark. Conversely, Cochrane review authors face the dual challenge of keeping their summary within RevMan's 400 to 850-word window while ensuring the entire review does not breach the 12,000-word ceiling introduced for focused reviews in July 2026.
Reduce the word count to a target while facts, numbers and citations stay, returned as the same editable file. When authors use editing or condensing tools on a `.docx` manuscript, they must configure target word counts mindfully. Aiming for 235 words on a 250-word journal target leaves a vital safety buffer for portal count discrepancies, while Cochrane summaries must never be cut below the mandatory 400-word floor. While such tools are designed to preserve formatting, numbers, and citations, authors must personally verify that their final plain summary satisfies publisher AI declarations (such as Taylor & Francis's four-point PLS statement) and accurately conveys all essential study findings.
- Floor and ceiling audit: Ensure Cochrane summaries fall strictly within 400 to 850 words (including the title), and confirm journal summaries respect the 200- or 250-word ceiling.
- Statistical jargon purge: Strip away any remaining confidence intervals (`95% CI`), P-values, relative risks, or technical GRADE ratings (`low-certainty evidence`) that violate lay readability.
- Readability metric check: Review sentence length against the NHS HRA 20-word benchmark and ensure paragraphs do not exceed 3 sentences.
- Audit trail and declaration: Embed the required publisher AI declaration in the manuscript and archive the pre-edited `.docx` version in institutional storage.
Frequently Asked Questions
Can I simply cut sentences from my technical abstract to create a Plain Language Summary? No. A technical abstract is written for specialist peers and relies heavily on statistical measures, methodological acronyms, and formal terminology (such as confidence intervals or trial designs). A Plain Language Summary must be written in non-technical prose, explain concepts in everyday language, and explicitly exclude statistical jargon like confidence intervals and risk of bias ratings.
What happens if my Cochrane Plain Language Summary is under 400 words? It will violate Cochrane submission requirements. Cochrane explicitly defines both a floor and a ceiling for its Plain Language Summaries: the summary "should be over 400 words and must not exceed 850 words" (including the title). If you condense your PLS below 400 words, editorial screening will flag it for expansion to ensure sufficient context and explanatory clarity for non-specialist readers.
Why does Taylor & Francis charge $1,200 for post-publication Plain Language Summaries? Taylor & Francis offers two distinct pathways for Plain Language Summaries. Option #1 is free and peer-reviewed: authors include the PLS directly in their submitted Word manuscript under the heading "Plain Language Summary" between the Abstract and Introduction, where it is typeset with the article and indexed on PubMed. Option #2 is a post-publication promotional service costing $1,200 (€1,000 / £850), which is published as supplementary material and is not indexed on PubMed.
Does using AI to condense my Plain Language Summary violate journal ethics? Not automatically, provided you adhere to publisher-specific disclosure policies and retain author responsibility. For example, Taylor & Francis explicitly allows AI-assisted drafting and condensing of an author's own work for a PLS, provided authors include a four-point Declaration of AI use and retain original drafts. Similarly, Wiley requires transparent disclosure for substantial AI assistance and forbids tools that claim training rights over author content.
Sources
- Cochrane: Word count in RevMan — Official guidance on the 400 to 850-word limit for Plain Language Summaries in RevMan.
- Cochrane: Introducing word limits for Cochrane Reviews and Protocols — July 1, 2026 announcement establishing the 12,000-word ceiling for focused reviews including the PLS.
- Cochrane: Guidance for writing a Cochrane Plain language summary — Handbook supplementary guidance detailing the ban on confidence intervals and GRADE jargon.
- Taylor & Francis: Plain Language Summary (PLS) Guidelines for Authors — Guidance establishing the 250-word benchmark, manuscript placement, PubMed indexing, and post-publication fees.
- Taylor & Francis: Using AI in your research and manuscript preparations — Editorial policy permitting AI-assisted PLS drafting under a four-point Declaration of AI use.
- Wiley Editing Services: Lay Summaries — Service benchmark specifying 200 words for non-technical research summaries.
- Wiley: Best Practice Guidelines on Publishing Ethics — Guidelines governing substantial AI development disclosures and prohibitions on training-rights claims.
- UK NHS Health Research Authority (HRA): Writing a plain language (lay) summary of your research findings — Best practice recommendations for 20-word sentences and 3-sentence paragraphs.
KEEP READING